Escolar Documentos
Profissional Documentos
Cultura Documentos
19 Demencia PDF
19 Demencia PDF
OBJETIVO:
Orientar os Mdicos de Famlia e Comunidade no reconhecimento e diagnstico
da demncia do idoso.
CONFLITO DE INTERESSE:
Nenhum conflito de interesse declarado.
INTRODUO
Para os indivduos com suspeita de sndrome a CIBIC-plus, que tambm utiliza informaes
demencial, a combinao de uma escala dos cuidadores para avaliar o desfecho global.
funcional que avalia atividades da vida diria e Para avaliao funcional ou das atividades da
um teste cognitivo aumenta a acurcia para o vida diria tm sido utilizados instrumentos
diagnstico dessa doena em uma populao como a escala de deteriorao progressiva (PDS).
como a nossa, ou seja, heterognea do ponto de Para avaliao das alteraes do comportamento
vista social e cultural. O Clinical Dementia e dos sintomas psiquitricos tm sido utilizadas
Rating (CDR) avalia a cognio e o compor- cada vez mais escalas como Neuropsychiatric
tamento, alm da influncia das perdas Inventory (NPI) e o Behavioral Pathology in
cognitivas na capacidade de realizar adequa- Alzheimers Disease Rating Scale (BEHAVE-
damente as atividades da vida diria. Esse AD). Esses testes so muito utilizados em
instrumento pode evitar o vis da utilizao do estudos (pesquisas), especialmente para avaliar
desempenho populacional como referncia, j a resposta ao tratamento medicamentoso. No
que compara cada indivduo consigo mesmo e so utilizados por mdicos em ateno primria
vlido para classificar o grau de demncia entre sade, sendo na maioria das vezes aplicados
os idosos13(D). por outros profissionais, como psiclogos.
14. Clarfield AM. The decreasing prevalence of 21. Ruitenberg A, van Swieten JC, Witteman
reversible dementias: an updated meta- JC, Mehta KM, van Duijn CM, Hofman
analysis. Arch Intern Med 2003;163: A, et al. Alcohol consumption and risk of
2219-29. dementia: the Rotterdam Study. Lancet
2002;359:281-6.
15. Nitrini R, Caramelli P, Bottino CM,
Damasceno BP, Brucki SM, Anghinah R, et 22. Clarke R, Daly L, Robinson K, Naughten
al. Diagnosis of Alzheimers disease in Brazil: E, Cahalane S, Fowler B, et al.
diagnostic criteria and auxiliary tests. Hyperhomocysteinemia: an independent
Recommendations of the Scientific risk factor for vascular disease. N Engl J
Department of Cognitive Neurology and Med 1991;324:1149-55.
Aging of the Brazilian Academy of Neurology.
Arq Neuropsiquiatr 2005;63:713-9. 23. Almeida OP. Can we prevent Alzheimers
disease? Rev Bras Psiquiatr 2005;27:
16. Braffman B, Drayer BP, Anderson RE, 264-5.
Davis PC, Deck MD, Hasso AN, et al.
Dementia. American College of Radiology.
24. Frank B, Gupta S. A review of antioxidants
ACR Appropriateness Criteria. Radiology
and Alzheimer s disease. Ann Clin
2000;215(Suppl):525-33.
Phsychiatry 2005;17:269-86.
17. Kantarci K, Jack CR Jr. Neuroimaging in
Alzheimer disease: an evidence-based review. 25. Avila R, Bottino CM. Cognitive changes
Neuroimaging Clin N Am 2003;13:197-209. update among elderly with depressive
syndrome. Rev Bras Psiquiatr 2006;28:
18. Cummings JL, Frank JC, Cherry D, 316-20.
Kohatsu ND, Kemp B, Hewett L, el at.
Guidelines for managing Alzheimers 26. Wilson RS, Barnes LL, Mendes de Leon
disease: part I. Assessment. Am Fam CF, Aggarwal NT, Schneider JS, Bach J,
Physician 2002;65:2263-72. et al. Depressive symptoms, cognitive
decline, and risk of AD in older persons.
19. Farrer LA, Cupples LA, Haines JL, Hyman Neurology 2002;59:364-70.
B, Kukull WA, Mayeux R, et al. Effects of
age, sex, and ethnicity on the association
27. Seidler A, Bernhardt T, Nienhaus A,
between apolipoprotein E genotype and
Frlich L. Association between the
Alzheimer disease. A meta-analysis. APOE
and Alzheimer Disease Meta Analysis phsychosocial network and dementia: a
Consortium. JAMA 1997;278:1349-56. case-control study. J Psychiatr Res
2003;37:89-98.
20. Luchsinger JA, Tang MX, Siddiqui M, Shea
S, Mayeux R. Alcohol intake and risk of 28. Seidler A, Nienhaus A, Bernhardt T,
dementia. J Am Geriatr Soc 2004;52:540-6. Kauppinen T, Elo AL, Frlich L.
29. The Canadian Study of Health and Aging: 34. Shumaker SA, Legault C, Kuller L, Rapp
risk factors for Alzheimers disease in SR, Thal L, Lane DS, et al. Conjugated
Canada. Neurology 1994;44:2073-80. equine estrogens and incidence of probable
dementia and mild cognitive impairment
30. Mortimer JA, van Duijn CM, Chandra in postmenopausal women: Womens
V, Fratiglioni L, Graves AB, Heyman Health Initiative Memory Study. JAMA
A, et al. Head trauma as a risk factor 2004;291:2947-58.
for Alzheimers disease: a collaborative
re-analysis of case-control studies. 35. Verdoux H, Lagnaoui R, Begaud B. Is
EURODEM Risk Factors Research benzodiazepine use a risk factor for
Group. Int J Epidemiol 1991;20(Suppl cognitive decline and dementia? A literature
2):S28-35. review of epidemiological studies. Psychol
Med 2005;35:307-15.
31. Bowen J, Teri L, Kukull W, McCormick
W, McCurry SM, Larson EB. Progression 36. Whitmer RA, Sidney S, Selby J, Johnston
to dementia in patients with isolated SC, Yaffe K. Midlife cardiovascular risk
memory loss. Lancet 1997;349:763-5. factors and risk of dementia in late life.
Neurology 2005;64:277-81.
32. Daly E, Zaitchik D, Copeland M,
Schmahmann J, Gunther J, Albert M. 37. Tanzi RE. A genetic dichotomy model for
Predicting conversion to Alzheimer disease the inheritance of Alzheimers disease and
using standardized clinical information. common age-related disorders. J Clin Invest
Arch Neurol 2000;57:675-80. 1999;104:1175-9.
33. Etminan M, Gill S, Samii A. Effect of 38. Borenstein AR, Copenhaver CI, Mortimer
non-steroidal anti-inflammatory drugs on JA. Early-life risk factors for Alzheimer disease.
risk of Alzheimers disease: systematic Alzheimer Dis Assoc Disord 2006;20:63-72.